RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medica Sur SAB de CV Stock

Medica Sur SAB de CV Net Income 2024

Medica Sur SAB de CV Net Income

123.28 M MXN

Ticker

MEDICAB.MX

ISIN

MXP510121215

WKN

A1JHBB

In 2024, Medica Sur SAB de CV's profit amounted to 123.28 M MXN, a -80.59% increase from the 634.98 M MXN profit recorded in the previous year.

The Medica Sur SAB de CV Net Income history

YEARNET INCOME (undefined MXN)
2024e0.12
20230.63
20220.95
20211.15
20200.56
20190.14
20180.16
20170.23
20160.14
20150.24
20140.35
20130.38
20120.3
20110.22
20100.23
20090.24
20080.19
20070.22
20060.19
20050.14
20040.13

Medica Sur SAB de CV Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medica Sur SAB de CV, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medica Sur SAB de CV from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medica Sur SAB de CV’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medica Sur SAB de CV. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medica Sur SAB de CV’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medica Sur SAB de CV’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medica Sur SAB de CV’s growth potential.

Medica Sur SAB de CV Revenue, EBIT and net profit per share

DateMedica Sur SAB de CV RevenueMedica Sur SAB de CV EBITMedica Sur SAB de CV Net Income
2024e5.96 B MXN0 MXN123.28 M MXN
20234.13 B MXN623.89 M MXN634.98 M MXN
20223.87 B MXN574.76 M MXN949.8 M MXN
20213.81 B MXN734.56 M MXN1.15 B MXN
20203.19 B MXN626.96 M MXN558.83 M MXN
20193.7 B MXN365.3 M MXN140.55 M MXN
20183.61 B MXN399.01 M MXN156.15 M MXN
20173.43 B MXN510.91 M MXN231.8 M MXN
20162.51 B MXN211.7 M MXN142.63 M MXN
20152.28 B MXN331.24 M MXN241.02 M MXN
20142.29 B MXN464.7 M MXN349.08 M MXN
20132.26 B MXN496.7 M MXN379.8 M MXN
20122.09 B MXN401.7 M MXN300.5 M MXN
20111.92 B MXN323.2 M MXN224 M MXN
20101.82 B MXN355 M MXN231.3 M MXN
20091.78 B MXN372.6 M MXN236.8 M MXN
20081.56 B MXN302.3 M MXN193.7 M MXN
20071.4 B MXN288.1 M MXN216.3 M MXN
20061.24 B MXN268.1 M MXN194.2 M MXN
20051.07 B MXN234.4 M MXN144.5 M MXN
2004952.2 M MXN204.9 M MXN131.8 M MXN

Medica Sur SAB de CV stock margins

The Medica Sur SAB de CV margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medica Sur SAB de CV. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medica Sur SAB de CV.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medica Sur SAB de CV's sales revenue. A higher gross margin percentage indicates that the Medica Sur SAB de CV retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medica Sur SAB de CV's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medica Sur SAB de CV's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medica Sur SAB de CV's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medica Sur SAB de CV. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medica Sur SAB de CV's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medica Sur SAB de CV Margin History

Medica Sur SAB de CV Gross marginMedica Sur SAB de CV Profit marginMedica Sur SAB de CV EBIT marginMedica Sur SAB de CV Profit margin
2024e35.34 %0 %2.07 %
202335.34 %15.11 %15.38 %
202235.35 %14.86 %24.56 %
202139.45 %19.27 %30.28 %
202037.77 %19.63 %17.5 %
201929.54 %9.88 %3.8 %
201830.8 %11.06 %4.33 %
201733.89 %14.89 %6.76 %
201630.94 %8.43 %5.68 %
201531.13 %14.54 %10.58 %
201434.5 %20.27 %15.23 %
201336.7 %22.01 %16.83 %
201234.07 %19.22 %14.38 %
201131.92 %16.79 %11.64 %
201035.16 %19.48 %12.69 %
200935.87 %20.88 %13.27 %
200834.88 %19.43 %12.45 %
200737.17 %20.62 %15.48 %
200636.83 %21.68 %15.7 %
200536.24 %21.92 %13.51 %
200436.84 %21.52 %13.84 %

Medica Sur SAB de CV Aktienanalyse

What does Medica Sur SAB de CV do?

Medica Sur SAB de CV is a leading Mexican healthcare company that was originally founded in 1982. Headquartered in Mexico City, Medica Sur operates hospitals, medical clinics, laboratories, and diagnostic centers throughout the country. The company aims to provide comprehensive and high-quality healthcare and has earned an outstanding reputation through its innovative medical technology and expertise. The core business of Medica Sur includes the operation of seven hospitals and clinical facilities in various parts of the country. These facilities provide medical services in general medicine, internal medicine, neurology, oncology, gynecology, urology, pediatrics, ophthalmology, and clinical psychiatry. The company also operates its own laboratory and diagnostic center, where a wide range of tests are performed, including X-rays and CT scans, blood tests, and biopsy examinations. Medica Sur also has a subsidiary called Hospitales Angeles, which specializes in cosmetic surgery. These facilities offer a wide range of beauty treatments, including liposuction, breast augmentation, facelifts, and Botox injections. Another important business area for Medica Sur is education and research. The company operates a prestigious training program for medical professionals such as nurses, specialists, and general practitioners. Furthermore, Medica Sur is active in medical research and invests in innovative technologies and scientific developments aimed at improving the quality and effectiveness of medical care. One of Medica Sur's biggest innovations is the use of robotics in surgery. The company utilizes robots that can respond to the surgeon's movements, thereby enabling higher precision in performing operations. The use of this technology has contributed to the advancement of surgery and opened up new treatment options for patients. Overall, Medica Sur's business model is designed to provide comprehensive and high-quality healthcare in Mexico tailored to the needs and expectations of patients. The company aims to be a leading healthcare company that utilizes innovative technologies and top-notch expertise to improve people's lives. Medica Sur SAB de CV ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Medica Sur SAB de CV's Profit Margins

The profit margins of Medica Sur SAB de CV represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medica Sur SAB de CV's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Medica Sur SAB de CV's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Medica Sur SAB de CV's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Medica Sur SAB de CV’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Medica Sur SAB de CV stock

How much profit has Medica Sur SAB de CV made this year?

Medica Sur SAB de CV has made 123.28 M MXN this year.

How has the profit developed compared to last year?

The profit has increased by -80.59% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Medica Sur SAB de CV publish its earnings?

Medica Sur SAB de CV publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Medica Sur SAB de CV?

The profits of Medica Sur SAB de CV are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Medica Sur SAB de CV?

You can learn more about the earnings of Medica Sur SAB de CV by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Medica Sur SAB de CV pay?

Over the past 12 months, Medica Sur SAB de CV paid a dividend of 13.06 MXN . This corresponds to a dividend yield of about 37.65 %. For the coming 12 months, Medica Sur SAB de CV is expected to pay a dividend of 13.06 MXN.

What is the dividend yield of Medica Sur SAB de CV?

The current dividend yield of Medica Sur SAB de CV is 37.65 %.

When does Medica Sur SAB de CV pay dividends?

Medica Sur SAB de CV pays a quarterly dividend. This is distributed in the months of June, October, June, June.

How secure is the dividend of Medica Sur SAB de CV?

Medica Sur SAB de CV paid dividends every year for the past 4 years.

What is the dividend of Medica Sur SAB de CV?

For the upcoming 12 months, dividends amounting to 13.06 MXN are expected. This corresponds to a dividend yield of 37.65 %.

In which sector is Medica Sur SAB de CV located?

Medica Sur SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medica Sur SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medica Sur SAB de CV from 5/16/2024 amounting to 1.5 MXN, you needed to have the stock in your portfolio before the ex-date on 5/14/2024.

When did Medica Sur SAB de CV pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of Medica Sur SAB de CV in the year 2023?

In the year 2023, Medica Sur SAB de CV distributed 10.485 MXN as dividends.

In which currency does Medica Sur SAB de CV pay out the dividend?

The dividends of Medica Sur SAB de CV are distributed in MXN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medica Sur SAB de CV

Our stock analysis for Medica Sur SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medica Sur SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.